0
$0.00

LL-37 5mg (CAP-18)

Customer Review 0
Rated 5 out of 5

$84.99

Researched Benefits:

  • Facilitates analysis of hCAP-18 proteolytic cleavage into biologically active LL-37
  • Supports investigation of FPR2-mediated chemotaxis and pro-inflammatory signaling in leukocytes
  • Enables research on membrane permeabilization mechanisms within multidrug-resistant bacterial assays
  • Useful for evaluating P2X7 receptor activation and NLRP3 inflammasome assembly
Share it :
Payment-Icon.png
International Shipment

Your orders are shipped seamlessly between countries

30 Days Warranty

You have the right to return your orders within 30 days.

Secure Payment

Your payments are secure with our private security network.

Description

LL-37 5mg (CAP-18) is a human cathelicidin-derived research peptide widely studied for its roles in host defense, immune modulation, and tissue repair. Sourced from superior quality raw materials and synthesized using cutting-edge technology, our LL-37 ensures top-notch purity and efficacy for detailed and rigorous research initiatives.

Key Features:

  • Produced in compliance with the strictest industry standards for purity and consistency.

  • Each batch undergoes stringent quality checks to ensure uniform reliability.

  • Supplied in a lyophilized format to maintain stability and efficacy under recommended storage conditions.

Applications:

  • Investigating antimicrobial mechanisms against diverse pathogens.

  • Exploring biofilm disruption and synergy with conventional antimicrobials.

  • Examining roles in wound healing, inflammation control, and immune modulation.

Specifications and Documentation

  • Material Safety Data Sheet (MSDS): Coming Soon.

  • Handling and Storage Instructions: Coming Soon.

LL-37 5mg (CAP-18) is highly regarded in the research sector for its prospective applications in antimicrobial, immunology, and wound-healing studies, offering researchers a valuable tool for profound exploration of these topics.

0